Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Anagnostics Enters Sales Cooperation with Analis S.A.

Published: Monday, December 10, 2012
Last Updated: Monday, December 10, 2012
Bookmark and Share
Company enters cooperation for Belgium and Luxembourg.

The Belgian company is specialized on clinical diagnostics and distributes Anagnostics’ innovative laboratory in the areas of drugs of abuse screening, personalized medicine (oncology) and sepsis diagnostics.

Since this summer Analis S.A. from Suarlée (near Namur) offers Anagnostics’ diagnostic products for drugs of abuse screening and personalized medicine.

In the coming months the sales portfolio will be enlarged by tests supporting the diagnosis and therapy of sepsis.

Analis and Anagnostics aim to serve hospitals in the Belux countries by offering truly innovative products and first class service.

“Analis is specialized on clinical diagnostics for a broad and loyal customer base and emphasizes first class support and advice of customers. Therewith Analis is the ideal partner for the distribution of our laboratory tests in Belgium and Luxembourg”, comments Christoph Reschreiter, CEO of Anagnostics Bioanalysis GmbH.

Guy Stukkens, CEO of Analis S.A. is looking forward to the sales cooperation: “We clearly see the trend towards more specific as well as more targeted and faster diagnostics, which is offered by multiplexed diagnostics. Anagnostics reacted on this need perfectly well. With the hyborg device and the test portfolio Anagnostics offers good market opportunities. The fast and efficient testing of drugs of abuse consumption ensures access to therapy institutions. The simple and highly sensitive tests in personalized medicine are particularly advantageous for small and medium sized pathologies, because cost efficiency is ensured even with low sample numbers.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Anagnostics and Molzym Form Strategic Alliance Fighting Sepsis
Agreement and partnership to commonly develop hybcell Pathogens DNA.
Monday, July 09, 2012
Ramcon A/S (Denmark) Distributes and Supports Anagnostics Products
Ramcon covers the Northern European countries and serves customers in Denmark, Sweden, Norway, Finland and Iceland with a highly specialized sales force.
Thursday, April 12, 2012
Scientific News
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
Making Virus Sensors Cheap and Simple
Researchers at The University of Texas at Austin demonstrated the ability to detect single viruses in a solution containing murine cytomegalovirus (MCMV).
Heart Defect Prediction Technology Could Lead to Earlier, More Informed Treatment
Experimental method uses genetics-guided biomechanics, patient-specific stem cells.
Biosensor Detects Molecules Linked to Cancer, Alzheimer's and Parkinson's
Novel biosensor has been proven capable of detecting molecules associated with neurodegenerative diseases and some types of cancer.
Big Data Can Save Lives
The sharing of genetic information from millions of cancer patients around the world could be key to revolutionising cancer prevention and care, according to a leading cancer expert from Queen's University Belfast.
Fast, Simple Test for Colitis
A minimally invasive screening for ulcerative colitis using emerging infrared technology could be a rapid and cost-effective method for detecting disease that eliminates the need for biopsies and intrusive testing of the human body.
Scans Reveal Babies of Mothers with Gestational Diabetes Have More Body Fat
Researchers at Imperial College London have found that the babies born to mothers with gestational diabetes have more body fat at two months of age compared to babies born to healthy mothers.
New Device Could Improve Cancer Detection
UBC researchers develop a microfluidic device to capture circulating tumor cells.
Plasma Biomarkers for Breast Cancer Diagnosis
Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!